These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22948149)

  • 1. Characterization of conformation-dependent prion protein epitopes.
    Kang HE; Weng CC; Saijo E; Saylor V; Bian J; Kim S; Ramos L; Angers R; Langenfeld K; Khaychuk V; Calvi C; Bartz J; Hunter N; Telling GC
    J Biol Chem; 2012 Oct; 287(44):37219-32. PubMed ID: 22948149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination.
    Kang HE; Bian J; Kane SJ; Kim S; Selwyn V; Crowell J; Bartz JC; Telling GC
    J Biol Chem; 2020 Jul; 295(30):10420-10433. PubMed ID: 32513872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
    Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
    Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the prion protein using recombinant antibodies.
    Williamson RA; Peretz D; Pinilla C; Ball H; Bastidas RB; Rozenshteyn R; Houghten RA; Prusiner SB; Burton DR
    J Virol; 1998 Nov; 72(11):9413-8. PubMed ID: 9765500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
    Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
    Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
    Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
    Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
    Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.
    Stanker LH; Scotcher MC; Lin A; McGarvey J; Prusiner SB; Hnasko R
    Hybridoma (Larchmt); 2012 Oct; 31(5):314-24. PubMed ID: 23098297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants.
    Harmeyer S; Pfaff E; Groschup MH
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():937-45. PubMed ID: 9568991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.
    Wei X; Roettger Y; Tan B; He Y; Dodel R; Hampel H; Wei G; Haney J; Gu H; Johnstone BH; Liu J; Farlow MR; Du Y
    J Biol Chem; 2012 Apr; 287(16):12858-66. PubMed ID: 22362783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.
    Khalili-Shirazi A; Kaisar M; Mallinson G; Jones S; Bhelt D; Fraser C; Clarke AR; Hawke SH; Jackson GS; Collinge J
    Biochim Biophys Acta; 2007 Nov; 1774(11):1438-50. PubMed ID: 17936697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiaggregating antibody raised against human PrP 106-126 recognizes pathological and normal isoforms of the whole prion protein.
    Hanan E; Priola SA; Solomon B
    Cell Mol Neurobiol; 2001 Dec; 21(6):693-703. PubMed ID: 12043842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
    Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
    Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
    Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
    Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrP antibody binding-induced epitope modulation evokes immunocooperativity.
    Chang B; Miller MW; Bulgin MS; Sorenson-Melson S; Balachandran A; Chiu A; Rubenstein R
    J Neuroimmunol; 2008 Dec; 205(1-2):94-100. PubMed ID: 18977037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.